{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:48:46Z","timestamp":1792068526912,"version":"4.4.0"},"reference-count":102,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:p>OBJECTIVE. Juvenile GM2 gangliosidosis is a group of inherited neurodegenerative diseases caused by deficiency of lysosomal \u03b2-hexosaminidase resulting in GM2 ganglioside accumulation in brain. The purpose of this study was to delineate the natural history of the condition and identify genotype-phenotype correlations that might be helpful in predicting the course of the disease in individual patients.<\/jats:p><jats:p>METHODS. A cohort of 21 patients with juvenile GM2 gangliosidosis, 15 with the Tay-Sachs variant and 6 with the Sandhoff variant, was studied prospectively in 2 centers. Our experience was compared with previously published reports on 134 patients. Information about clinical features, \u03b2-hexosaminidase enzyme activity, and mutation analysis was collected.<\/jats:p><jats:p>RESULTS. In our cohort of patients, the mean (\u00b1SD) age of onset of symptoms was 5.3 \u00b1 4.1 years, with a mean follow-up time of 8.4 years. The most common symptoms at onset were gait disturbances (66.7%), incoordination (52.4%), speech problems (28.6%), and developmental delay (28.6%). The age of onset of gait disturbances was 7.1 \u00b1 5.6 years. The mean time for progression to becoming wheelchair-bound was 6.2 \u00b1 5.5 years. The mean age of onset of speech problems was 7.0 \u00b1 5.6 years, with a mean time of progression to anarthria of 5.6 \u00b1 5.3 years. Muscle wasting (10.6 \u00b1 7.4 years), proximal weakness (11.1 \u00b1 7.7 years), and incontinence of sphincters (14.6 \u00b1 9.7 years) appeared later in the course of the disease. Psychiatric disturbances and neuropathy were more prevalent in patients with the Sandhoff variant than in those with the Tay-Sachs variant. However, dysphagia, sphincter incontinence, and sleep problems occurred earlier in those with the Tay-Sachs variant. Cerebellar atrophy was the most common finding on brain MRI (52.9%). The median survival time among the studied and reviewed patients was 14.5 years. The genotype-phenotype correlation revealed that in patients with the Tay-Sachs variant, the presence of R178H and R499H mutations was predictive of an early onset and rapidly progressive course. The presence of either G269S or W474C mutations was associated with a later onset of symptoms along with a more slowly progressive disease course.<\/jats:p><jats:p>CONCLUSIONS. Juvenile GM2 gangliosidosis is clinically heterogeneous, not only in terms of age of onset and clinical features but also with regard to the course of the disease. In general, the earlier the onset of symptoms, the more rapidly the disease progresses. The Tay-Sachs and Sandhoff variants differed somewhat in the frequency of specific clinical characteristics. Speech deterioration progressed more rapidly than gait abnormalities in both the Tay-Sachs variant and Sandhoff variant groups. Among patients with the Tay-Sachs variant, the HEXA genotype showed a significant correlation with the clinical course.<\/jats:p>","DOI":"10.1542\/peds.2006-0588","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T00:26:31Z","timestamp":1159835191000},"page":"e1550-e1562","source":"Crossref","is-referenced-by-count":178,"title":["The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported"],"prefix":"10.1542","volume":"118","author":[{"given":"Gustavo H. B.","family":"Maegawa","sequence":"first","affiliation":[{"name":"Divisions of Clinical and Metabolic Genetics"},{"name":"Research Institute, Hospital for Sick Children"},{"name":"Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Stockley","sequence":"additional","affiliation":[{"name":"Paediatric Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tropak","sequence":"additional","affiliation":[{"name":"Research Institute, Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Blaser","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics, Diagnostic Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Kok","sequence":"additional","affiliation":[{"name":"Centro do Genoma Humano, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[{"name":"Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Mahuran","sequence":"additional","affiliation":[{"name":"Research Institute, Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Divisions of Clinical and Metabolic Genetics"},{"name":"Research Institute, Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2021120823205567200_R1","unstructured":"Inui K, Grebner EE, Jackson LG, Wenger DA. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Am J Hum Genet.\u20081983;35:551\u2013564"},{"key":"2021120823205567200_R2","doi-asserted-by":"crossref","unstructured":"Mahuran DJ. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta.\u20081999;1455:105\u2013138","DOI":"10.1016\/S0925-4439(99)00074-5"},{"key":"2021120823205567200_R3","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA.\u20081999;281:249\u2013254","DOI":"10.1001\/jama.281.3.249"},{"key":"2021120823205567200_R4","doi-asserted-by":"crossref","unstructured":"Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr.\u20082000;159(suppl 3):S192\u2013S195","DOI":"10.1007\/PL00014401"},{"key":"2021120823205567200_R5","unstructured":"Kaback MM, Zeiger RS, Reynolds LW, Sonneborn M. Approaches to the control and prevention of Tay-Sachs disease. Prog Med Genet.\u20081974;10:103\u2013134"},{"key":"2021120823205567200_R6","doi-asserted-by":"crossref","unstructured":"Triggs-Raine BL, Feigenbaum AS, Natowicz M, et al. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews: a comparison of DNA-based and enzyme-based tests. N Engl J Med.\u20081990;323:6\u201312","DOI":"10.1056\/NEJM199007053230102"},{"key":"2021120823205567200_R7","unstructured":"Gravel R, Kaback M, Proia R, Sandhoff K, Suzuki K, Suzuki K. The GM2 gangliosidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001:3827\u20133876"},{"key":"2021120823205567200_R8","doi-asserted-by":"crossref","unstructured":"Rapin I, Suzuki K, Suzuki K, Valsamis MP. Adult (chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol.\u20081976;33:120\u2013130","DOI":"10.1001\/archneur.1976.00500020048008"},{"key":"2021120823205567200_R9","doi-asserted-by":"crossref","unstructured":"Argov Z, Navon R. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann Neurol.\u20081984;16:14\u201320","DOI":"10.1002\/ana.410160105"},{"key":"2021120823205567200_R10","doi-asserted-by":"crossref","unstructured":"Navon R, Argov Z, Frisch A. Hexosaminidase A deficiency in adults. Am J Med Genet.\u20081986;24:179\u2013196","DOI":"10.1002\/ajmg.1320240123"},{"key":"2021120823205567200_R11","doi-asserted-by":"crossref","unstructured":"Specola N, Vanier MT, Goutieres F, Mikol J, Aicardi J. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology.\u20081990;40:145\u2013150","DOI":"10.1212\/WNL.40.1.145"},{"key":"2021120823205567200_R12","doi-asserted-by":"crossref","unstructured":"Mitsuo K, Nakano T, Kobayashi T, Goto I, Taniike M, Suzuki K. Juvenile Sandhoff disease: a Japanese patient carrying a mutation identical to that found earlier in a Canadian patient. J Neurol Sci.\u20081990;98:277\u2013286","DOI":"10.1016\/0022-510X(90)90269-S"},{"key":"2021120823205567200_R13","doi-asserted-by":"crossref","unstructured":"Maia M, Alves D, Ribeiro G, Pinto R, Sa Miranda MC. Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients. Neuropediatrics.\u20081990;21:18\u201323","DOI":"10.1055\/s-2008-1071451"},{"key":"2021120823205567200_R14","doi-asserted-by":"crossref","unstructured":"Boustany RM, Tanaka A, Nishimoto J, Suzuki K. Genetic cause of a juvenile form of Tay-Sachs disease in a Lebanese child. Ann Neurol.\u20081991;29:104\u2013107","DOI":"10.1002\/ana.410290120"},{"key":"2021120823205567200_R15","doi-asserted-by":"crossref","unstructured":"Nishimoto J, Tanaka A, Nanba E, Suzuki K. Expression of the beta-hexosaminidase alpha subunit gene with the four-base insertion of infantile Jewish Tay-Sachs disease. J Biol Chem.\u20081991;266:14306\u201314309","DOI":"10.1016\/S0021-9258(18)98684-9"},{"key":"2021120823205567200_R16","doi-asserted-by":"crossref","unstructured":"Yuksel A, Yalcinkaya C, Islak C, Gunduz E, Seven M. Neuroimaging findings of four patients with Sandhoff disease. Pediatr Neurol.\u20081999;21:562\u2013565","DOI":"10.1016\/S0887-8994(99)00041-7"},{"key":"2021120823205567200_R17","doi-asserted-by":"crossref","unstructured":"Fox J, Li YT, Dawson G, et al. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis). Acta Neuropathol (Berl).\u20081999;97:57\u201362","DOI":"10.1007\/s004010050955"},{"key":"2021120823205567200_R18","unstructured":"Unnikrishnan AG, Danda S, Seshadri MS. Juvenile Sandhoff disease. Indian Pediatr.\u20082001;38:89\u201392"},{"key":"2021120823205567200_R19","doi-asserted-by":"crossref","unstructured":"Chow GC, Clarke JT, Banwell BL. Late-onset GM2 gangliosidosis presenting as burning dysesthesias. Pediatr Neurol.\u20082001;25:59\u201361","DOI":"10.1016\/S0887-8994(01)00280-6"},{"key":"2021120823205567200_R20","doi-asserted-by":"crossref","unstructured":"Hendriksz CJ, Corry PC, Wraith JE, Besley GT, Cooper A, Ferrie CD. Juvenile Sandhoff disease: nine new cases and a review of the literature. J Inherit Metab Dis.\u20082004;27:241\u2013249","DOI":"10.1023\/B:BOLI.0000028777.38551.5a"},{"key":"2021120823205567200_R21","doi-asserted-by":"crossref","unstructured":"Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med.\u20082005;7:119\u2013123","DOI":"10.1097\/01.GIM.0000154300.84107.75"},{"key":"2021120823205567200_R22","doi-asserted-by":"crossref","unstructured":"Navon R, Khosravi R, Melki J, et al. Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene. Ann Neurol.\u20081997;41:631\u2013638","DOI":"10.1002\/ana.410410512"},{"key":"2021120823205567200_R23","doi-asserted-by":"crossref","unstructured":"Zaroff CM, Neudorfer O, Morrison C, Pastores GM, Rubin H, Kolodny EH. Neuropsychological assessment of patients with late onset GM2 gangliosidosis. Neurology.\u20082004;62:2283\u20132286","DOI":"10.1212\/01.WNL.0000130498.19019.02"},{"key":"2021120823205567200_R24","unstructured":"Bernheimer H, Seitelberger F. On the behavior of brain gangliosides in 2 cases of late infantile amaurotic idiocy [in German]. Wien Klin Wochenschr.\u20081968;80:163\u2013164 passim"},{"key":"2021120823205567200_R25","doi-asserted-by":"crossref","unstructured":"Derry DM, Fawcett JS, Andermann F, Wolfe LS. Late infantile systemic lipidosis: major monosialogangliosidosis\u2014delineation of two types. Neurology.\u20081968;18:340\u2013348","DOI":"10.1212\/WNL.18.4.340"},{"key":"2021120823205567200_R26","doi-asserted-by":"crossref","unstructured":"Derry DM, Wolfe LS. Ganglioside analyses of serial cryostat sections through Ammon's horn and cerebellar folia. Exp Brain Res.\u20081968;5:32\u201344","DOI":"10.1007\/BF00239903"},{"key":"2021120823205567200_R27","doi-asserted-by":"crossref","unstructured":"Suzuki K, Rapin I, Suzuki Y, Ishii N. Juvenile GM2-gangliosidosis. Neurology.\u20081970;20:190\u2013204","DOI":"10.1212\/WNL.20.2.190"},{"key":"2021120823205567200_R28","doi-asserted-by":"crossref","unstructured":"Suzuki Y, Suzuki K. Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis. Neurology.\u20081970;20:848\u2013851","DOI":"10.1212\/WNL.20.9.848"},{"key":"2021120823205567200_R29","doi-asserted-by":"crossref","unstructured":"Okada S, Veath ML, O'Brien JS. Juvenile GM2 gangliosidosis: partial deficiency of hexosaminidase A. J Pediatr.\u20081970;77:1063\u20131065","DOI":"10.1016\/S0022-3476(70)80096-8"},{"key":"2021120823205567200_R30","doi-asserted-by":"crossref","unstructured":"De Negri M, Borri PF, Palladini G, Lauro G, Bugiani O. Early juvenile GM2 gangliosidosis (morphological and chemical study of a cerebral biopsy) [in Italian]. Acta Neurol (Napoli).\u20081970;25:547\u2013550","DOI":"10.1001\/archneur.1971.00490010024003"},{"key":"2021120823205567200_R31","doi-asserted-by":"crossref","unstructured":"Menkes JH, O'Brien JS, Okada S, Grippo J, Andrews JM, Cancilla PA. Juvenile GM2 gangliosidosis: biochemical and ultrastructural studies on a new variant of Tay-Sachs disease. Arch Neurol.\u20081971;25:14\u201322","DOI":"10.1001\/archneur.1971.00490010024003"},{"key":"2021120823205567200_R32","unstructured":"Borri PL, Bugiani O, Lauro G, Palladini G, Ravera G. Juvenile G M2-gangliosidosis: a morphological and chemical study of a cerebral biopsy. Acta Neurol Belg.\u20081971;71:309\u2013318"},{"key":"2021120823205567200_R33","doi-asserted-by":"crossref","unstructured":"Buxton P, Cumings JN, Ellis RB, et al. A case of GM2 gangliosidosis of late onset. J Neurol Neurosurg Psychiatry.\u20081972;35:685\u2013692","DOI":"10.1136\/jnnp.35.5.685"},{"key":"2021120823205567200_R34","doi-asserted-by":"crossref","unstructured":"Brett EM, Ellis RB, Haas L, et al. Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients. Arch Dis Child.\u20081973;48:775\u2013785","DOI":"10.1136\/adc.48.10.775"},{"key":"2021120823205567200_R35","doi-asserted-by":"crossref","unstructured":"Spence MW, Ripley BA, Embil JA, Tibbles JA. A new variant of Sandhoff's disease. Pediatr Res.\u20081974;8:628\u2013637","DOI":"10.1203\/00006450-197406000-00003"},{"key":"2021120823205567200_R36","unstructured":"Andermann EAF, Carpenter S, Karpati G, Grimes D, Wolfe LS. Late onset GM2 gangliosidosis (juvenile Tay-Sachs disease) in two Lebanese families. Can J Neurol Sci.\u20081976;3:150\u2013153."},{"key":"2021120823205567200_R37","doi-asserted-by":"crossref","unstructured":"MacLeod PM, Wood S, Jan JE, Applegarth DA, Dolman CL. Progressive cerebellar ataxia, spasticity, psychomotor retardation, and hexosaminidase deficiency in a 10-year-old child: juvenile Sandhoff disease. Neurology.\u20081977;27:571\u2013573","DOI":"10.1212\/WNL.27.6.571"},{"key":"2021120823205567200_R38","doi-asserted-by":"crossref","unstructured":"Brandt S, Clausen J, Diemer NH, et al. Juvenile neurolipidosis of Bernheimer-Seitelberger's type: histopathological and biochemical findings. Acta Neurol Scand.\u20081977;56:587\u2013602","DOI":"10.1111\/j.1600-0404.1977.tb01464.x"},{"key":"2021120823205567200_R39","doi-asserted-by":"crossref","unstructured":"Goldie WD, Holtzman D, Suzuki K. Chronic hexosaminidase A and B deficiency. Ann Neurol.\u20081977;2:156\u2013158","DOI":"10.1002\/ana.410020212"},{"key":"2021120823205567200_R40","unstructured":"Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population. Prog Clin Biol Res.\u20081977;18:161\u2013188"},{"key":"2021120823205567200_R41","doi-asserted-by":"crossref","unstructured":"Wood S. Juvenile Sandhoff disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion. Hum Genet.\u20081978;41:325\u2013329","DOI":"10.1007\/BF00284766"},{"key":"2021120823205567200_R42","doi-asserted-by":"crossref","unstructured":"Felding I, Hultberg B. An atypical form of Sandhoff's disease: case report and biochemical studies. Neuropadiatrie.\u20081978;9:74\u201383","DOI":"10.1055\/s-0028-1085411"},{"key":"2021120823205567200_R43","doi-asserted-by":"crossref","unstructured":"Chester MA, Hultberg B, Liedholm H, Ockerman PA. A new N-acetyl-beta-D-hexosaminidase disease with late onset of progressive neurological symptoms. Hum Hered.\u20081979;29:124\u2013128","DOI":"10.1159\/000153028"},{"key":"2021120823205567200_R44","unstructured":"Johnson WG, Cohen CS, Miranda AF, Waran SP, Chutorian AM. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies. Am J Hum Genet.\u20081980;32:508\u2013518"},{"key":"2021120823205567200_R45","doi-asserted-by":"crossref","unstructured":"Goldman JE, Yamanaka T, Rapin I, Adachi M, Suzuki K. The AB-variant of GM2-gangliosidosis: clinical, biochemical, and pathological studies of two patients. Acta Neuropathol (Berl).\u20081980;52:189\u2013202","DOI":"10.1007\/BF00705807"},{"key":"2021120823205567200_R46","doi-asserted-by":"crossref","unstructured":"Willner JP, Grabowski GA, Gordon RE, Bender AN, Desnick RJ. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. Neurology.\u20081981;31:787\u2013798","DOI":"10.1212\/WNL.31.7.787"},{"key":"2021120823205567200_R47","doi-asserted-by":"crossref","unstructured":"Navon R, Argov Z, Brand N, Sandbank U. Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype. Neurology.\u20081981;31:1397\u20131401","DOI":"10.1212\/WNL.31.11.1397"},{"key":"2021120823205567200_R48","doi-asserted-by":"crossref","unstructured":"Johnson WG, Wigger HJ, Karp HR, Glaubiger LM, Rowland LP. Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype. Ann Neurol.\u20081982;11:11\u201316","DOI":"10.1002\/ana.410110103"},{"key":"2021120823205567200_R49","unstructured":"Kolodny EH, Lyerla T, Raghavan SS, Seashore G, Fogelson H, Pope HG. Significance of hexosaminidase A deficiency in adults. Neurology.\u20081982;32:A81\u2013A82"},{"key":"2021120823205567200_R50","doi-asserted-by":"crossref","unstructured":"Meek D, Wolfe LS, Andermann E, Andermann F. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. Ann Neurol.\u20081984;15:348\u2013352","DOI":"10.1002\/ana.410150408"},{"key":"2021120823205567200_R51","doi-asserted-by":"crossref","unstructured":"Charrow J, Inui K, Wenger DA. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity. Clin Genet.\u20081985;27:78\u201384","DOI":"10.1111\/j.1399-0004.1985.tb00188.x"},{"key":"2021120823205567200_R52","doi-asserted-by":"crossref","unstructured":"Mitsumoto H, Sliman RJ, Schafer IA, et al. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol.\u20081985;17:378\u2013385","DOI":"10.1002\/ana.410170413"},{"key":"2021120823205567200_R53","doi-asserted-by":"crossref","unstructured":"Mantovani JF, Vidgoff J, Cass M. Brain dysfunction in an adolescent with the neuromuscular form of hexosaminidase deficiency. Dev Med Child Neurol.\u20081985;27:664\u2013667","DOI":"10.1111\/j.1469-8749.1985.tb14139.x"},{"key":"2021120823205567200_R54","doi-asserted-by":"crossref","unstructured":"Parnes S, Karpati G, Carpenter S, Kin NM, Wolfe LS, Suranyi L. Hexosaminidase-A deficiency presenting as atypical juvenile-onset spinal muscular atrophy. Arch Neurol.\u20081985;42:1176\u20131180","DOI":"10.1001\/archneur.1985.04060110058016"},{"key":"2021120823205567200_R55","doi-asserted-by":"crossref","unstructured":"Oates CE, Bosch EP, Hart MN. Movement disorders associated with chronic GM2 gangliosidosis: case report and review of the literature. Eur Neurol.\u20081986;25(2):154\u2013159","DOI":"10.1159\/000116100"},{"key":"2021120823205567200_R56","doi-asserted-by":"crossref","unstructured":"Adams C, Green S. Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review. Dev Med Child Neurol.\u20081986;28:236\u2013243","DOI":"10.1111\/j.1469-8749.1986.tb03860.x"},{"key":"2021120823205567200_R57","doi-asserted-by":"crossref","unstructured":"Cashman NR, Antel JP, Hancock LW, et al. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Ann Neurol.\u20081986;19:568\u2013572","DOI":"10.1002\/ana.410190608"},{"key":"2021120823205567200_R58","doi-asserted-by":"crossref","unstructured":"Hardie RJ, Young EP, Morgan-Hughes JA. Hexosaminidase A deficiency presenting as juvenile progressive dystonia. J Neurol Neurosurg Psychiatry.\u20081988;51:446\u2013447","DOI":"10.1136\/jnnp.51.3.446"},{"key":"2021120823205567200_R59","doi-asserted-by":"crossref","unstructured":"Lichtenberg P, Navon R, Wertman E, Dasberg H, Lerer B. Post-partum psychosis in adult GM2 gangliosidosis: a case report. Br J Psychiatry.\u20081988;153:387\u2013389","DOI":"10.1192\/bjp.153.3.387"},{"key":"2021120823205567200_R60","doi-asserted-by":"crossref","unstructured":"Rubin M, Karpati G, Wolfe LS, Carpenter S, Klavins MH, Mahuran DJ. Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency. J Neurol Sci.\u20081988;87:103\u2013119","DOI":"10.1016\/0022-510X(88)90058-5"},{"key":"2021120823205567200_R61","doi-asserted-by":"crossref","unstructured":"Goebel HH, Stolte G, Kustermann-Kuhn B, Harzer K. B1 variant of GM2 gangliosidosis in a 12-year-old patient. Pediatr Res.\u20081989;25:89\u201393","DOI":"10.1203\/00006450-198901000-00019"},{"key":"2021120823205567200_R62","unstructured":"Nakano R, Wakamatsu N, Tsuji S, Matsumura G, Miyatake T. Juvenile Sandhoff disease with local panatrophy: a case report [in Japanese]. Rinsho Shinkeigaku.\u20081989;29:1032\u20131038"},{"key":"2021120823205567200_R63","doi-asserted-by":"crossref","unstructured":"Thomas PK, Young E, King RH. Sandhoff disease mimicking adult-onset bulbospinal neuronopathy. J Neurol Neurosurg Psychiatry.\u20081989;52:1103\u20131106","DOI":"10.1136\/jnnp.52.9.1103"},{"key":"2021120823205567200_R64","unstructured":"Tanaka A, Ohno K, Sandhoff K, et al. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients [published correction appears in Am J Hum Genet. 1991;48:176]. Am J Hum Genet.\u20081990;46:329\u2013339"},{"key":"2021120823205567200_R65","doi-asserted-by":"crossref","unstructured":"Paw BH, Moskowitz SM, Uhrhammer N, Wright N, Kaback MM, Neufeld EF. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. J Biol Chem.\u20081990;265:9452\u20139457","DOI":"10.1016\/S0021-9258(19)38870-2"},{"key":"2021120823205567200_R66","unstructured":"dos Santos MR, Tanaka A, sa Miranda MC, Ribeiro MG, Maia M, Suzuki K. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. Am J Hum Genet.\u20081991;49:886\u2013890"},{"key":"2021120823205567200_R67","doi-asserted-by":"crossref","unstructured":"Barnes D, Misra VP, Young EP, Thomas PK, Harding AE. An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry.\u20081991;54:1112\u20131113","DOI":"10.1136\/jnnp.54.12.1112"},{"key":"2021120823205567200_R68","doi-asserted-by":"crossref","unstructured":"Suzuki K, Vanier MT. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype. Dev Neurosci.\u20081991;13:288\u2013294","DOI":"10.1159\/000112175"},{"key":"2021120823205567200_R69","doi-asserted-by":"crossref","unstructured":"Nardocci N, Bertagnolio B, Rumi V, Angelini L. Progressive dystonia symptomatic of juvenile GM2 gangliosidosis. Mov Disord.\u20081992;7:64\u201367","DOI":"10.1002\/mds.870070113"},{"key":"2021120823205567200_R70","doi-asserted-by":"crossref","unstructured":"Harmon DL, Gardner-Medwin D, Stirling JL. Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene. J Med Genet.\u20081993;30:123\u2013128","DOI":"10.1136\/jmg.30.2.123"},{"key":"2021120823205567200_R71","doi-asserted-by":"crossref","unstructured":"Streifler JY, Gornish M, Hadar H, Gadoth N. Brain imaging in late-onset GM2 gangliosidosis. Neurology.\u20081993;43:2055\u20132058","DOI":"10.1212\/WNL.43.10.2055"},{"key":"2021120823205567200_R72","doi-asserted-by":"crossref","unstructured":"Hurowitz GI, Silver JM, Brin MF, Williams DT, Johnson WG. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings. J Neuropsychiatry Clin Neurosci.\u20081993;5:30\u201336","DOI":"10.1176\/jnp.5.1.30"},{"key":"2021120823205567200_R73","doi-asserted-by":"crossref","unstructured":"Richard MM, Erenberg G, Triggs-Raine BL. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease. Biochem Mol Med.\u20081995;55:74\u201376","DOI":"10.1006\/bmme.1995.1035"},{"key":"2021120823205567200_R74","doi-asserted-by":"crossref","unstructured":"Philippart M, Carrel RE, Landing BH. Tay-Sachs disease with atypical chronic course and limited brain storage: alpha-locus hexosaminidase genetic compound. Neurochem Res.\u20081995;20:1323\u20131328","DOI":"10.1007\/BF00992507"},{"key":"2021120823205567200_R75","doi-asserted-by":"crossref","unstructured":"Ribeiro MG, Sonin T, Pinto RA, et al. Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant. J Med Genet.\u20081996;33:341\u2013343","DOI":"10.1136\/jmg.33.4.341"},{"key":"2021120823205567200_R76","doi-asserted-by":"crossref","unstructured":"De Gasperi R, Gama Sosa MA, Battistini S, et al. Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180\u2192His) in the Hex A alpha-chain gene. Neurology.\u20081996;47:547\u2013552","DOI":"10.1212\/WNL.47.2.547"},{"key":"2021120823205567200_R77","doi-asserted-by":"crossref","unstructured":"Hund E, Grau A, Fogel W, et al. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci.\u20081997;145:25\u201331","DOI":"10.1016\/S0022-510X(96)00233-X"},{"key":"2021120823205567200_R78","doi-asserted-by":"crossref","unstructured":"Beck M, Sieber N, Goebel HH. Progressive cerebellar ataxia in juvenile GM2-gangliosidosis type Sandhoff. Eur J Pediatr.\u20081998;157:866\u2013867","DOI":"10.1007\/s004310050955"},{"key":"2021120823205567200_R79","doi-asserted-by":"crossref","unstructured":"Eiris J, Chabas A, Coll MJ, Castro-Gago M. Late infantile and juvenile form of GM2-gangliosidosis variant B1 [in Spanish]. Rev Neurol.\u20081999;29:435\u2013438","DOI":"10.33588\/rn.2905.99302"},{"key":"2021120823205567200_R80","doi-asserted-by":"crossref","unstructured":"Felderhoff-Mueser U, Sperner J, Konstanzcak P, Navon R, Weschke B. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease. J Child Neurol.\u20082001;16:377\u2013380","DOI":"10.1177\/088307380101600514"},{"key":"2021120823205567200_R81","doi-asserted-by":"crossref","unstructured":"Grosso S, Farnetani MA, Berardi R, et al. GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol.\u20082003;250:17\u201321","DOI":"10.1007\/s00415-003-0925-3"},{"key":"2021120823205567200_R82","doi-asserted-by":"crossref","unstructured":"Van Hoof F, Evrard Ph, Hers HG. An unusual case of GM2-gangliosidosis with deficiency of hexosaminidase A and B. Adv Exp Med Biol.\u20081972;19:343\u2013350","DOI":"10.1007\/978-1-4757-6570-0_24"},{"key":"2021120823205567200_R83","doi-asserted-by":"crossref","unstructured":"Lowden JA, Skomorowski MA, Henderson F, Kaback M. Automated assay of hexosaminidases in serum. Clin Chem.\u20081973;19:1345\u20131349","DOI":"10.1093\/clinchem\/19.12.1345"},{"key":"2021120823205567200_R84","doi-asserted-by":"crossref","unstructured":"Bapat B, Ethier M, Neote K, Mahuran D, Gravel RA. Cloning and sequence analysis of a cDNA encoding the beta-subunit of mouse beta-hexosaminidase. FEBS Lett.\u20081988;237:191\u2013195","DOI":"10.1016\/0014-5793(88)80199-6"},{"key":"2021120823205567200_R85","doi-asserted-by":"crossref","unstructured":"Neote K, Bapat B, Dumbrille-Ross A, et al. Characterization of the human HEXB gene encoding lysosomal beta-hexosaminidase. Genomics.\u20081988;3:279\u2013286","DOI":"10.1016\/0888-7543(88)90116-4"},{"key":"2021120823205567200_R86","doi-asserted-by":"crossref","unstructured":"Neote K, McInnes B, Mahuran DJ, Gravel RA. Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J Clin Invest.\u20081990;86:1524\u20131531","DOI":"10.1172\/JCI114871"},{"key":"2021120823205567200_R87","doi-asserted-by":"crossref","unstructured":"Brown CA, McInnes B, de Kremer RD, Mahuran DJ. Characterization of two HEXB gene mutations in Argentinean patients with Sandhoff disease. Biochim Biophys Acta.\u20081992;1180:91\u201398","DOI":"10.1016\/0925-4439(92)90031-H"},{"key":"2021120823205567200_R88","doi-asserted-by":"crossref","unstructured":"McInnes B, Brown CA, Mahuran DJ. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease. Biochim Biophys Acta.\u20081992;1138:315\u2013317","DOI":"10.1016\/0925-4439(92)90009-C"},{"key":"2021120823205567200_R89","doi-asserted-by":"crossref","unstructured":"McInnes B, Potier M, Wakamatsu N, et al. An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds. J Clin Invest.\u20081992;90:306\u2013314","DOI":"10.1172\/JCI115863"},{"key":"2021120823205567200_R90","doi-asserted-by":"crossref","unstructured":"Stockley TL, Ray PN. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease. Methods Mol Biol.\u20082003;217:131\u2013141","DOI":"10.1385\/1-59259-330-5:131"},{"key":"2021120823205567200_R91","unstructured":"Volk BW, Adachi M, Schneck L, Saifer A, Kleinberg W. G5-ganglioside variant of systemic late infantile lipidosis: generalized gangliosidosis. Arch Pathol.\u20081969;87:393\u2013403"},{"key":"2021120823205567200_R92","doi-asserted-by":"crossref","unstructured":"Nakano T, Suzuki K. Genetic cause of a juvenile form of Sandhoff disease: abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. J Biol Chem.\u20081989;264:5155\u20135158","DOI":"10.1016\/S0021-9258(18)83712-7"},{"key":"2021120823205567200_R93","doi-asserted-by":"crossref","unstructured":"Dlott B, d'Azzo A, Quon DV, Neufeld EF. Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase. J Biol Chem.\u20081990;265:17921\u201317927","DOI":"10.1016\/S0021-9258(18)38251-6"},{"key":"2021120823205567200_R94","doi-asserted-by":"crossref","unstructured":"Mark BL, Mahuran DJ, Cherney MM, Zhao D, Knapp S, James MN. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol.\u20082003;327:1093\u20131109","DOI":"10.1016\/S0022-2836(03)00216-X"},{"key":"2021120823205567200_R95","doi-asserted-by":"crossref","unstructured":"Henrissat B, Bairoch A. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J.\u20081993;293:781\u2013788","DOI":"10.1042\/bj2930781"},{"key":"2021120823205567200_R96","doi-asserted-by":"crossref","unstructured":"Kytzia HJ, Sandhoff K. Evidence for two different active sites on human beta-hexosaminidase A: interaction of GM2 activator protein with beta-hexosaminidase A. J Biol Chem.\u20081985;260:7568\u20137572","DOI":"10.1016\/S0021-9258(17)39645-X"},{"key":"2021120823205567200_R97","doi-asserted-by":"crossref","unstructured":"Ohno K, Suzuki K. Mutation in GM2-gangliosidosis B1 variant. J Neurochem.\u20081988;50:316\u2013318","DOI":"10.1111\/j.1471-4159.1988.tb13266.x"},{"key":"2021120823205567200_R98","doi-asserted-by":"crossref","unstructured":"Matsuzawa F, Aikawa S, Sakuraba H, et al. Structural basis of the GM2 gangliosidosis B variant. J Hum Genet.\u20082003;48:582\u2013589","DOI":"10.1007\/s10038-003-0082-7"},{"key":"2021120823205567200_R99","doi-asserted-by":"crossref","unstructured":"Paw BH, Kaback MM, Neufeld EF. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Proc Natl Acad Sci U S A. 1989;86:2413\u20132417","DOI":"10.1073\/pnas.86.7.2413"},{"key":"2021120823205567200_R100","doi-asserted-by":"crossref","unstructured":"Petroulakis E, Cao Z, Clarke JT, Mahuran DJ, Lee G, Triggs-Raine B. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis. Hum Mutat.\u20081998;11:432\u2013442","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<432::AID-HUMU3>3.0.CO;2-Z"},{"key":"2021120823205567200_R101","unstructured":"Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O. MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol.\u20082005;26:2037\u20132042"},{"key":"2021120823205567200_R102","doi-asserted-by":"crossref","unstructured":"Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M. Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol.\u20082005;35:1081\u20131085","DOI":"10.1007\/s00247-005-1542-3"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/e1550\/1117367\/zpe011060e1550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/e1550\/1117367\/zpe011060e1550.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T01:36:58Z","timestamp":1683596218000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/5\/e1550\/69926\/The-Natural-History-of-Juvenile-or-Subacute-GM2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0588","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}